Immunohistochemical localization of type D retrovirus serotype 1 in the digestive tract of rhesus monkeys with simian AIDS.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 2172543)

Published in J Med Primatol on January 01, 1990

Authors

A A Lackner1, P F Moore, P A Marx, R J Munn, M B Gardner, L J Lowenstine

Author Affiliations

1: California Primate Research Center, University of California, Davis.

Articles by these authors

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol (2001) 8.64

Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer (1974) 6.53

Amphotropic host range of naturally occuring wild mouse leukemia viruses. J Virol (1976) 5.43

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med (1996) 5.35

Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer (1969) 4.99

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol (2000) 4.87

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell (2001) 4.79

Mortality of sea lions along the central California coast linked to a toxic diatom bloom. Nature (2000) 3.82

A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59

Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol (1989) 3.43

Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst (1977) 3.35

Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol (1997) 3.33

Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. Science (1986) 3.11

Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer (1986) 3.09

High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J Virol (1978) 2.96

Experimental transmission of feline fibrosarcoma to cats and dogs. Nature (1970) 2.91

C-type virus released from cultured human rhabdomyosarcoma cells. Nat New Biol (1972) 2.78

Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop. J Virol (1996) 2.77

AIDS serology testing in low- and high-risk groups. JAMA (1985) 2.74

Type C viruses of wild mice: characterization and natural history of amphotropic, ecotropic, and xenotropic MuLv. Curr Top Microbiol Immunol (1978) 2.56

Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol (1998) 2.49

In vitro isolation of stable rat sarcoma viruses. Proc Natl Acad Sci U S A (1978) 2.41

The injection century: massive unsterile injections and the emergence of human pathogens. Lancet (2001) 2.38

The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol (2001) 2.38

Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J Virol (2000) 2.37

Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol (2000) 2.26

Isolation of a neurotropic type C virus. Science (1973) 2.19

Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J Virol (1997) 2.16

Replication of cat leukemia virus in cell suspension cultures. Nature (1969) 2.15

Simian AIDS: isolation of a type D retrovirus and transmission of the disease. Science (1984) 2.10

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Exp Med (2000) 2.10

Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 2.08

Cultivation in vitro of cells derived from a human osteosarcoma. Cancer (1971) 2.06

Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J Virol (1990) 2.04

Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. Virology (1987) 2.04

Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J Neuropathol Exp Neurol (1974) 2.00

Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses (1998) 1.99

Different rat-derived transforming retroviruses code for an immunologically related intracellular phosphoprotein. Proc Natl Acad Sci U S A (1979) 1.98

Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol (1990) 1.97

Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol (2001) 1.96

Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol (1991) 1.93

Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88

Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86

Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab Invest (1992) 1.83

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res (1986) 1.83

Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res Hum Retroviruses (1999) 1.80

Prognostic factors for treatment of malignant lymphoma in dogs. J Am Vet Med Assoc (1994) 1.77

Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am J Pathol (1992) 1.76

Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J Acquir Immune Defic Syndr (1991) 1.75

Dietary fat and cancer trends--a critique. Fed Proc (1978) 1.74

Retroviral spongiform polioencephalomyelopathy. Rev Infect Dis (1985) 1.72

Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J Virol (1991) 1.71

Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol (1992) 1.70

Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol (1994) 1.69

Mucosal immunity, HIV transmission, and AIDS. Lab Invest (1993) 1.69

Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J Virol (1993) 1.68

Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus. J Virol (1998) 1.66

Comparative studies on the structural phosphoproteins of mammalian type C viruses. J Virol (1975) 1.66

Current information on feline and canine cancers and relationship or lack of relationship to human cancer. J Natl Cancer Inst (1971) 1.61

Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol (2002) 1.57

Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus. Lancet (1987) 1.54

Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis (2000) 1.52

A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity (1995) 1.52

Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab Invest (1994) 1.50

Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med (1998) 1.50

Tumor morphology and immunohistochemical expression of estrogen receptor, progesterone receptor, p53, and Ki67 in urogenital carcinomas of California sea lions (Zalophus californianus). Vet Pathol (2009) 1.49

Ultrastructural comparison of the retroviruses associated with human and simian acquired immunodeficiency syndromes. Lab Invest (1985) 1.48

Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology (1998) 1.47

Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol (2007) 1.47

The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med (1986) 1.46

Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma. Nature (1984) 1.45

Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins. J Virol (1974) 1.45

Experimental vaccine protection against feline immunodeficiency virus. AIDS Res Hum Retroviruses (1991) 1.42

Unusually high incidence of spontaneous lymphomas in wild house mice. J Natl Cancer Inst (1973) 1.41

Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res Hum Retroviruses (1994) 1.40

Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol (2003) 1.40

Epidemic of acquired immunodeficiency in rhesus monkeys. Lancet (1983) 1.39

Isolation and characterization of Sendai virus temperature-sensitive mutants. J Virol (1974) 1.38

Spontaneous tumors of aging wild house mice. Incidence, pathology, and C-type virus expression. J Natl Cancer Inst (1973) 1.37

The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril (1992) 1.36

Isolation of a new serotype of simian acquired immune deficiency syndrome type D retrovirus from Celebes black macaques (Macaca nigra) with immune deficiency and retroperitoneal fibromatosis. J Virol (1985) 1.36

Origins of simian immunodeficiency virus infection in macaques at the New England Regional Primate Research Center. J Med Primatol (1995) 1.32

Akvr-1, a dominant murine leukemia virus restriction gene, is polymorphic in leukemia-prone wild mice. Proc Natl Acad Sci U S A (1980) 1.31

Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J Virol (1996) 1.31

Subviral components of a wild mouse embryo-derived type C oncornavirus. Virology (1973) 1.30

Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells. J Virol (1988) 1.29